// App-Quantinova.ai

AB0536 : EFFECT OF HYDROXYCHLOROQUINE TREATMENT IN MUCOCUTANEOUS MANIFESTATIONS IN PATIENTS WITH BEHÇET’S SYNDROME

Researchers

Presenter

  • F. Kerstens

Principal Investigators

  • S. Mohamed

  • I. Visman

  • F. Turkstra

  • C. Swearingen

  • Y. Yazici

Medical Centers

  • VUmc, Amsterdam, Netherlands

  • NYU Langone Health, Hospital for Joint Diseases, New York, United States of America

Locations

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Autoimmune (AI)

Disease

  • Behcet disease

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved